CUR Market Cap History



Below is a table of the CUR market cap history going back to 1/9/2017:

Date CUR Market Cap
1/9/201742.04M
2/28/201751.14M
4/30/201756.40M
7/31/201718.78M
10/31/201718.33M
2/28/201822.89M
4/30/201825.01M
7/31/201817.13M
10/31/201810.56M
2/28/20198.56M
4/30/201910.01M
7/18/20199.07M
8/8/20194.58M
12/31/201810.51M

Also see: CUR Shares Outstanding History
and CUR YTD Return
CUR Historical Market Cap:
-50.43% CAGR
CUR Historical Market Cap: +-50.43% CAGR

Mouse over chart for data details
1/9/2017 ...12/31/2018
Neuralstem is a clinical stage biopharmaceutical company that is utilizing its proprietary human neural stem cell technology to create a platform of therapies for the treatment of central nervous system diseases. Co.'s technology platform has produced four key assets, two in clinical development and two in preclinical development: its NSI-566 stem cell therapy program (clinical stage) for treatment of paralysis, NSI-189 small molecule program (clinical stage) for Major Depressive Disorder and NSI-532 for Alzheimer's Disease and NSI-577 indicated for potential use in treatment of human demyelinating diseases, both of which are second-generation stem cell therapy programs (preclinical stage). We show 14 historical shares outstanding datapoints in our CUR shares outstanding history coverage, used to compute CUR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CUR market cap history over the course of time is important for investors interested in comparing CUR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CUR versus a peer is one thing; comparing CUR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CUR can fluctuate over the course of history. With this page we aim to empower investors researching CUR by allowing them to research the CUR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CUR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neuralstem (CUR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CUTR Market Cap History
CVKD Market Cap History
CVRX Market Cap History
CVS Market Cap History
CWBR Market Cap History
CYCC Market Cap History
CYCN Market Cap History
CYH Market Cap History
CYRX Market Cap History
CYT Market Cap History
More Healthcare companies »

 

CUR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.